Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


Articles published in Int J Hematol

Retrieve available abstracts of 115 articles:
HTML format
Text format



Single Articles


    April 2017
  1. HATAKE K, Ogura M, Takada K, Taniwaki M, et al
    Ofatumumab combined with chlorambucil for previously untreated chronic lymphocytic leukemia: a phase I/II, open-label study in Japan.
    Int J Hematol. 2017 Apr 18. doi: 10.1007/s12185-017-2233.
    PubMed     Text format     Abstract available


  2. KE S, Li RC, Lu J, Meng FK, et al
    MicroRNA-192 regulates cell proliferation and cell cycle transition in acute myeloid leukemia via interaction with CCNT2.
    Int J Hematol. 2017 Apr 13. doi: 10.1007/s12185-017-2232.
    PubMed     Text format     Abstract available


  3. TAKAHASHI N, Nakaseko C, Kobayashi Y, Miyamura K, et al
    Long-term treatment with bosutinib in a phase 1/2 study in Japanese chronic myeloid leukemia patients resistant/intolerant to prior tyrosine kinase inhibitor treatment.
    Int J Hematol. 2017 Apr 13. doi: 10.1007/s12185-017-2239.
    PubMed     Text format     Abstract available


  4. IGUCHI A, Cho Y, Sugiyama M, Terashita Y, et al
    Bortezomib combined with standard induction chemotherapy in Japanese children with refractory acute lymphoblastic leukemia.
    Int J Hematol. 2017 Apr 11. doi: 10.1007/s12185-017-2235.
    PubMed     Text format     Abstract available


  5. ONG SY, Ho LP, Yeo PM, Ng HJ, et al
    Marked hypereosinophilia and rash as initial presentation of acute myeloid leukemia with t(8;21).
    Int J Hematol. 2017 Apr 7. doi: 10.1007/s12185-017-2230.
    PubMed     Text format    


  6. ZHANG R, Chen J, Huang H, Ma J, et al
    Primary fungal prophylaxis in acute leukemia patients with different risk factors: retrospective analysis from the CAESAR study.
    Int J Hematol. 2017 Apr 7. doi: 10.1007/s12185-017-2224.
    PubMed     Text format     Abstract available


  7. SUH KJ, Lee JY, Shin DY, Koh Y, et al
    Analysis of adverse events associated with dasatinib and nilotinib treatments in chronic-phase chronic myeloid leukemia patients outside clinical trials.
    Int J Hematol. 2017 Apr 4. doi: 10.1007/s12185-017-2225.
    PubMed     Text format     Abstract available


  8. YAGUCHI A, Ishibashi T, Terada K, Ueno-Yokohata H, et al
    EP300-ZNF384 fusion gene product up-regulates GATA3 gene expression and induces hematopoietic stem cell gene expression signature in B-cell precursor acute lymphoblastic leukemia cells.
    Int J Hematol. 2017 Apr 4. doi: 10.1007/s12185-017-2220.
    PubMed     Text format     Abstract available


    March 2017
  9. NAKAMAE H, Fujisawa S, Ogura M, Uchida T, et al
    Dasatinib versus imatinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia: a subanalysis of the DASISION 5-year final report.
    Int J Hematol. 2017 Mar 24. doi: 10.1007/s12185-017-2208.
    PubMed     Text format     Abstract available


  10. BARAKA A, Sherief LM, Kamal NM, Shorbagy SE, et al
    Detection of minimal residual disease in childhood B-acute lymphoblastic leukemia by 4-color flowcytometry.
    Int J Hematol. 2017 Mar 21. doi: 10.1007/s12185-017-2206.
    PubMed     Text format     Abstract available


  11. KATZ BZ, Herishanu Y
    Fragility of sub-cellular structures in chronic lymphocytic leukemia.
    Int J Hematol. 2017 Mar 21. doi: 10.1007/s12185-017-2218.
    PubMed     Text format    


  12. ISHIHARA T, Nogami K, Matsumoto T, Nomura A, et al
    Potentially life-threatening coagulopathy associated with simultaneous reduction in coagulation and fibrinolytic function in pediatric acute leukemia after hematopoietic stem-cell transplantation.
    Int J Hematol. 2017 Mar 16. doi: 10.1007/s12185-017-2213.
    PubMed     Text format     Abstract available


  13. HASSAN IB, Zaabi MR, Alam A, Hashim MJ, et al
    Characteristics features and factors influencing early death in Acute promyelocytic leukemia; Experience from United Arab Emirates (UAE).
    Int J Hematol. 2017 Mar 14. doi: 10.1007/s12185-017-2211.
    PubMed     Text format     Abstract available


    February 2017
  14. MOLTENI A, Riva M, Ravano E, Marbello L, et al
    Clofarabine-based chemotherapy as a bridge to transplant in the setting of refractory or relapsed acute myeloid leukemia, after at least one previous unsuccessful salvage treatment containing fludarabine: a single institution experience.
    Int J Hematol. 2017 Feb 20. doi: 10.1007/s12185-017-2198.
    PubMed     Text format     Abstract available


  15. SHIGEMATSU A, Kako S, Mitsuhashi K, Iwato K, et al
    Allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia who had central nervous system involvement: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation.
    Int J Hematol. 2017 Feb 14. doi: 10.1007/s12185-017-2197.
    PubMed     Text format     Abstract available


  16. IWASA M, Miura Y, Fujishiro A, Fujii S, et al
    Erratum to: Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells.
    Int J Hematol. 2017 Feb 9. doi: 10.1007/s12185-017-2182.
    PubMed     Text format    


  17. YOKOYAMA H, Takahashi N, Katsuoka Y, Inomata M, et al
    Evaluation of the safety and efficacy of recombinant soluble thrombomodulin for patients with disseminated intravascular coagulation associated with acute leukemia: multicenter prospective study by the Tohoku Hematology Forum.
    Int J Hematol. 2017 Feb 7. doi: 10.1007/s12185-017-2190.
    PubMed     Text format     Abstract available


  18. OGAWA Y, Izutsu K, Kiguchi T, Choi I, et al
    A multicenter, single-arm, Phase II clinical trial of bendamustine monotherapy in patients with chronic lymphocytic leukemia in Japan.
    Int J Hematol. 2017 Feb 3. doi: 10.1007/s12185-016-2178.
    PubMed     Text format     Abstract available


    January 2017
  19. REYNA-FIGUEROA J, Lagunas-Martinez A, Galindo-Delgado P, Fernandez-Bautista MF, et al
    Serum concentrations of apoptosis-associated molecules in septic children with leukemia, neutropenia and fever.
    Int J Hematol. 2017 Jan 31. doi: 10.1007/s12185-016-2175.
    PubMed     Text format     Abstract available


  20. OKSENHENDLER E, Turpin J, Lhote R, Cassar O, et al
    Persistent risk of adult T-cell leukemia/lymphoma after neonatal HTLV-1 infection through exchange transfusion.
    Int J Hematol. 2017 Jan 30. doi: 10.1007/s12185-016-2174.
    PubMed     Text format     Abstract available


  21. ANDO T, Yamazaki E, Ogusa E, Ishii Y, et al
    Body mass index is a prognostic factor in adult patients with acute myeloid leukemia.
    Int J Hematol. 2017 Jan 21. doi: 10.1007/s12185-017-2183.
    PubMed     Text format     Abstract available


  22. IWASA M, Miura Y, Fujishiro A, Fujii S, et al
    Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells.
    Int J Hematol. 2017 Jan 2. doi: 10.1007/s12185-016-2169.
    PubMed     Text format     Abstract available


  23. WAISBREN J, Dinner S, Altman J, Frankfurt O, et al
    Disease characteristics and prognosis of myelodysplastic syndrome presenting with isolated thrombocytopenia.
    Int J Hematol. 2017;105:44-51.
    PubMed     Text format     Abstract available


    December 2016
  24. SHIMOMURA Y, Maruoka H, Ishikawa T
    Marked response to imatinib mesylate in a patient with platelet-derived growth factor receptor beta-associated acute myeloid leukemia.
    Int J Hematol. 2016 Dec 20. doi: 10.1007/s12185-016-2167.
    PubMed     Text format     Abstract available


  25. ISMAIL MM, Abdulateef NA
    Bone marrow T-cell percentage: A novel prognostic indicator in acute myeloid leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


    November 2016
  26. MORITA M, Nishinaka Y, Kato I, Saida S, et al
    Dasatinib induces autophagy in mice with Bcr-Abl-positive leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  27. HAJI S, Shiratsuchi M, Matsushima T, Takamatsu A, et al
    Achievement of disease control with donor-derived EB virus-specific cytotoxic T cells after allogeneic peripheral blood stem cell transplantation for aggressive NK-cell leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  28. UEMURA M, Imataki O, Kawachi Y, Kawakami K, et al
    Charlson comorbidity index predicts poor outcome in CML patients treated with tyrosine kinase inhibitor.
    Int J Hematol. 2016;104:621-627.
    PubMed     Text format     Abstract available


  29. JUNG KS, Cho SH, Kim SJ, Ko YH, et al
    Clinical features and treatment outcome of Epstein-Barr virus-positive nodal T-cell lymphoma.
    Int J Hematol. 2016;104:591-595.
    PubMed     Text format     Abstract available


  30. RUBIO P, Campos B, Digiorge JA, Gallego MS, et al
    NPM1, FLT3 and CEBPA mutations in pediatric patients with AML from Argentina: incidence and prognostic value.
    Int J Hematol. 2016;104:582-590.
    PubMed     Text format     Abstract available


  31. MONIKA BELICKOVA M, Merkerova MD, Votavova H, Valka J, et al
    Up-regulation of ribosomal genes is associated with a poor response to azacitidine in myelodysplasia and related neoplasms.
    Int J Hematol. 2016;104:566-573.
    PubMed     Text format     Abstract available


    October 2016
  32. YANG W, Ernst P
    SET/MLL family proteins in hematopoiesis and leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  33. MAZUMDAR C, Majeti R
    The role of mutations in the cohesin complex in acute myeloid leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  34. SUKNUNTHA K, Thita T, Togarrati PP, Ratanachamnong P, et al
    Wnt signaling inhibitor FH535 selectively inhibits cell proliferation and potentiates imatinib-induced apoptosis in myeloid leukemia cell lines.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  35. BADAT M, Oyesanya F, Cervi P
    CLL with intra-cytoplasmic lymphocytic inclusion bodies.
    Int J Hematol. 2016;104:411-2.
    PubMed     Text format    


    September 2016
  36. KAWAMOTO S, Yamamoto K, Toyoda M, Yakushijin K, et al
    Constitutional t(8;22)(q24;q11.2) that mimics the variant Burkitt-type translocation in Philadelphia chromosome-positive chronic myeloid leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  37. TANAHASHI T, Sekiguchi N, Matsuda K, Matsumoto A, et al
    A screening method with lymphocyte percentage and proportion of granular lymphocytes in the peripheral blood for large granular lymphocyte (LGL) leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  38. TSUBOKURA Y, Satake A, Hotta M, Yoshimura H, et al
    Successful treatment with mogamulizumab followed by allogeneic hematopoietic stem-cell transplantation in adult T-cell leukemia/lymphoma: a report of two cases.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  39. SAKAMOTO K, Tanaka S, Tomoyasu C, Tomii T, et al
    Development of acute lymphoblastic leukemia with IgH-EPOR in a patient with secondary erythrocytosis.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  40. OGIYA D, Matsushita H, Murayama H, Ando K, et al
    Chediak-Higashi-like granules and waxy Auer bodies in a case of acute promyelocytic leukemia.
    Int J Hematol. 2016.
    PubMed     Text format    


  41. YAMAMOTO K, Minami Y, Kawamoto S, Yakushijin K, et al
    Sea-blue histiocytes in acute myeloid leukemia with trisomy 9.
    Int J Hematol. 2016.
    PubMed     Text format    


  42. LAM YM, Chan YF, Chan LC, Ng RK, et al
    Histone deacetylase inhibitors induce leukemia gene expression in cord blood hematopoietic stem cells expanded ex vivo.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  43. HINO A, Yoshida H, Tada Y, Koike M, et al
    Changes from imatinib mesylate to second generation tyrosine kinase inhibitors improve renal impairment with imatinib mesylate in chronic myelogenous leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  44. ICHIKAWA K, Edahiro Y, Gotoh A, Iiduka K, et al
    Co-occurrence of hyperleukocytosis and elevated fibrin-fibrinogen degradation product levels is a risk factor for early intracranial hemorrhage in patients with de novo acute leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  45. KWON JH, Koh YI, Yoon SS, Park S, et al
    Clinical outcome and efficacy of current anti-leukemic therapy for leptomeningeal involvement in acute myeloid leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  46. KUTLAY NY, Pekpak E, Altiner S, Ileri T, et al
    Prognostic impact of RUNX1 and ETV6 gene copy number on pediatric B-cell precursor acute lymphoblastic leukemia with or without hyperdiploidy.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  47. AOKI S, Firouzi S, Lopez Y, Yamochi T, et al
    Transition of adult T-cell leukemia/lymphoma clones during clinical progression.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  48. DAVILA ML, Sadelain M
    Biology and clinical application of CAR T cells for B cell malignancies.
    Int J Hematol. 2016;104:6-17.
    PubMed     Text format     Abstract available


    June 2016
  49. NISHI Y, Fukushima T, Nomura S, Tomoyose T, et al
    Characterization of patients with aggressive adult T-cell leukemia-lymphoma in Okinawa, Japan: a retrospective analysis of a large cohort.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  50. ZHANG X, Tu H, Yang Y, Wan Q, et al
    High IL-7 levels in the bone marrow microenvironment mediate imatinib resistance and predict disease progression in chronic myeloid leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  51. KURIYAMA T, Kawano N, Yamashita K, Kikuchi I, et al
    Two cases of primary adult T-cell leukemia/lymphoma of bone: case reports and a review of the literature.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  52. OSHIMA Y, Yuji K, Tojo A
    "Imatinib-induced gastric antral vascular ectasia" in a reporting system of the Japanese Adverse Drug Event Report database.
    Int J Hematol. 2016;103:596-8.
    PubMed     Text format    


  53. GARG S, Ghosh K, Madkaikar M
    Antigen expression on a putative leukemic stem cell population and AML blast.
    Int J Hematol. 2016;103:567-71.
    PubMed     Text format     Abstract available


  54. WANG X, Chu Y, Wang W, Yuan W, et al
    mTORC signaling in hematopoiesis.
    Int J Hematol. 2016;103:510-8.
    PubMed     Text format     Abstract available


    April 2016
  55. KOH K, Ogawa C, Okamoto Y, Kudo K, et al
    Phase 1 study of clofarabine in pediatric patients with relapsed/refractory acute lymphoblastic leukemia in Japan.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  56. AMMATUNA E
    Stepwise discriminant function analysis for rapid identification of acute promyelocytic leukemia: should this be the first choice to establish the diagnosis of APL?
    Int J Hematol. 2016.
    PubMed     Text format    


  57. HARADA M, Gale RP
    Commentary: How do haematopoietic cell transplants cure leukaemia?
    Int J Hematol. 2016;103:396-8.
    PubMed     Text format    


  58. MANABE A
    Guest Editorial: Inherited bone marrow failure and myelodysplasia in children: how much do we know about pediatric diseases?
    Int J Hematol. 2016;103:359.
    PubMed     Text format    


  59. SCHALK E, Heidel FH
    Leukemic mastopathy.
    Int J Hematol. 2016;103:357-8.
    PubMed     Text format    


    March 2016
  60. SARASHINA T, Iwabuchi H, Miyagawa N, Sekimizu M, et al
    Hematopoietic stem cell transplantation for pediatric mature B-cell acute lymphoblastic leukemia with non-L3 morphology and MLL-AF9 gene fusion: three case reports and review of the literature.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  61. LIU L, Yuan X
    Transient ischemic attack as an unusual initial manifestation of acute promyelocytic leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  62. ZHU H, Xu W, Liu H, Wang H, et al
    Expression of activated molecules on CD5B lymphocytes in autoimmune hemolytic anemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  63. SHIGEMURA T, Nishina S, Nakazawa H, Matsuda K, et al
    Early detection of Rhizopus DNA in the serum of a patient with rhino-orbital-cerebral mucormycosis following allogeneic hematopoietic stem cell transplantation.
    Int J Hematol. 2016;103:354-5.
    PubMed     Text format    


    February 2016
  64. SAIDA S
    Evolution of myeloid leukemia in children with Down syndrome.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  65. JIANG Y, Nakada D
    Cell intrinsic and extrinsic regulation of leukemia cell metabolism.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  66. GOTO S, Goto H, Yokosuka T
    The combination effects of bendamustine with antimetabolites against childhood acute lymphoblastic leukemia cells.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  67. KATAGIRI S, Gotoh M, Tone K, Akahane D, et al
    Fatal Cyberlindnera fabianii fungemia in a patient with mixed phenotype acute leukemia after umbilical cord blood transplantation.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  68. OTSUKA Y, Kondo T, Nakamoto Y, Haga H, et al
    18F-FDG PET/CT and MRI findings in a case of granulocytic sarcoma of the breast.
    Int J Hematol. 2016;103:117-8.
    PubMed     Text format    


  69. MITSUI T, Koiso H, Nakahashi H, Saitoh A, et al
    SF3B1 and IGHV gene mutation status predict poor prognosis in Japanese CLL patients.
    Int J Hematol. 2016;103:219-26.
    PubMed     Text format     Abstract available


  70. CHAVDA S, Liapis K
    Detection of mycobacteria in MGG-stained bone marrow smears.
    Int J Hematol. 2016;103:115-6.
    PubMed     Text format    


    January 2016
  71. SUBARI S, Baidoun F, Hreh M, Patnaik M, et al
    Prior hypomethylating agent use lacks impact on clinical outcome in patients with secondary acute myeloid leukemia arising from myelodysplastic syndromes treated with standard induction chemotherapy.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  72. YANADA M, Yamamoto Y, Iba S, Okamoto A, et al
    TP53 mutations in older adults with acute myeloid leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  73. KEINO D, Kinoshita A, Tomizawa D, Takahashi H, et al
    Residual disease detected by multidimensional flow cytometry shows prognostic significance in childhood acute myeloid leukemia with intermediate cytogenetics and negative FLT3-ITD: a report from the Tokyo Children's Cancer Study Group.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  74. CHEN Z, Li Y, Tong Y, Gao Q, et al
    Stepwise discriminant function analysis for rapid identification of acute promyelocytic leukemia from acute myeloid leukemia with multiparameter flow cytometry.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  75. HIRADE T, Abe M, Onishi C, Taketani T, et al
    Internal tandem duplication of FLT3 deregulates proliferation and differentiation and confers resistance to the FLT3 inhibitor AC220 by Up-regulating RUNX1 expression in hematopoietic cells.
    Int J Hematol. 2016;103:95-106.
    PubMed     Text format     Abstract available


    December 2015
  76. NAKAMURA Y, Tokita K, Nagasawa F, Takahashi W, et al
    Chronic myelogenous leukemia in chronic phase transforming into acute leukemia under treatment with dasatinib 4 months after diagnosis.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


    November 2015
  77. MOHREN M, Jentsch-Ullrich K, Koenigsmann M, Kropf S, et al
    High coagulation factor VIII and von Willebrand factor in patients with lymphoma and leukemia.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


  78. OKAMOTO Y, Koga Y, Inagaki J, Ozono S, et al
    Effective VCR/DEX pulse maintenance therapy in the KYCCSG ALL-02 protocol for pediatric acute lymphoblastic leukemia.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


  79. YANAGISAWA R, Nakazawa Y, Sakashita K, Saito S, et al
    Intrathecal donor lymphocyte infusion for isolated leukemia relapse in the central nervous system following allogeneic stem cell transplantation: a case report and literature review.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


  80. MENDIZABAL AM, Younes N, Levine PH
    Geographic and income variations in age at diagnosis and incidence of chronic myeloid leukemia.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


    October 2015
  81. KITAMURA K, Nishiyama T, Ishiyama K, Miyawaki S, et al
    Clinical usefulness of WT1 mRNA expression in bone marrow detected by a new WT1 mRNA assay kit for monitoring acute myeloid leukemia: a comparison with expression of WT1 mRNA in peripheral blood.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


  82. HATANAKA M, Miyamura T, Koh K, Taga T, et al
    Respiratory syncytial virus infection in infants with acute leukemia: a retrospective survey of the Japanese Pediatric Leukemia/Lymphoma Study Group.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


  83. AKIYAMA M, Yamaoka M, Mikami-Terao Y, Ohyama W, et al
    Somatic mosaic mutations of IDH1 and NPM1 associated with cup-like acute myeloid leukemia in a patient with Maffucci syndrome.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


  84. CHIBA S
    Guest editorial: pre-leukemia/pre-lymphoma-what is old, what is new?
    Int J Hematol. 2015.
    PubMed     Text format    


  85. TAKASHIMA S, Miyamoto T, Kamimura T, Yoshimoto G, et al
    Effects of conditioning intensity in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


  86. HIRASE S, Hasegawa D, Takahashi H, Moriwaki K, et al
    Absolute lymphocyte count at the end of induction therapy is a prognostic factor in childhood acute lymphoblastic leukemia.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


  87. HIRAMOTO R, Imamura T, Muramatsu H, Wang X, et al
    Serial investigation of PTPN11 mutation in nonhematopoietic tissues in a patient with juvenile myelomonocytic leukemia who was treated with unrelated cord blood transplantation.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


    September 2015
  88. KIKUMA T, Nakamachi Y, Noguchi Y, Okazaki Y, et al
    Erratum to: A new transcriptional variant and small azurophilic granules in an acute promyelocytic leukemia case with NPM1/RARA fusion gene.
    Int J Hematol. 2015.
    PubMed     Text format    


  89. TOMIZAWA D, Kato M, Takahashi H, Fujimura J, et al
    Favorable outcome in non-infant children with MLL-AF4-positive acute lymphoblastic leukemia: a report from the Tokyo Children's Cancer Study Group.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


  90. LI H, Kong X, Cui G, Ren C, et al
    Rapamycin restores p14, p15 and p57 expression and inhibits the mTOR/p70S6K pathway in acute lymphoblastic leukemia cells.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


  91. SUN H, Li Y, Zhang ZF, Ju Y, et al
    Increase in myeloid-derived suppressor cells (MDSCs) associated with minimal residual disease (MRD) detection in adult acute myeloid leukemia.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


  92. KIKUMA T, Nakamachi Y, Noguchi Y, Okazaki Y, et al
    A new transcriptional variant and small azurophilic granules in an acute promyelocytic leukemia case with NPM1/RARA fusion gene.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


    August 2015
  93. SHIMURA Y, Horiike S, Tsutsumi Y, Hatsuse M, et al
    The longitudinal analysis of large granular lymphocytosis in patients with Philadelphia chromosome-positive leukemia treated with dasatinib.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


  94. NOMOTO H, Takami A, Espinoza JL, Matsuo K, et al
    A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


  95. KOTTWITZ D, El Hadi H, El Amrani M, Cabezas S, et al
    Evaluation of a novel multiplex RT-qPCR assay for the quantification of leukemia-associated BCR-ABL1 translocation.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


    July 2015
  96. SONG JY, Khojeini EV, Dwyre DM, Jonas BA, et al
    B lymphoblastic leukemia with granules mimicking acute myeloid leukemia.
    Int J Hematol. 2015.
    PubMed     Text format    


  97. SAKURAI M, Mori T, Karigane D, Tozawa K, et al
    Unfavorable outcome of chronic myelogenous leukemia in adolescent and young adults treated with tyrosine kinase inhibitors.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


  98. MORITAKE H, Obara M, Sameshima N, Asada Y, et al
    Analysis of the molecular mechanism underlying bone marrow necrosis with acute lymphoblastic leukemia.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


  99. TACHIBANA T, Tanaka M, Hagihara M, Kawasaki R, et al
    Clinical significance of the administration of cytarabine or thiotepa in addition to total body irradiation and cyclophosphamide for allogeneic hematopoietic cell transplantation in patients with acute leukemia.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


  100. NAKAMAE H, Yoshida C, Miyata Y, Hidaka M, et al
    A new diagnostic kit, ODK-1201, for the quantitation of low major BCR-ABL mRNA level in chronic myeloid leukemia: correlation of quantitation with major BCR-ABL mRNA kits.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


  101. ZHI Y, Xie X, Wang R, Wang B, et al
    Serum level of miR-10-5p as a prognostic biomarker for acute myeloid leukemia.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


  102. TOMIZAWA D, Watanabe T, Hanada R, Horibe K, et al
    Outcome of adolescent patients with acute myeloid leukemia treated with pediatric protocols.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


  103. MICHELIS FV, Bril V, Lipton JH
    A case report and literature review of chronic graft-versus-host disease manifesting as polymyositis.
    Int J Hematol. 2015;102:144-6.
    PubMed     Text format     Abstract available


  104. HOUWING ME, Koopman-Coenen EA, Kersseboom R, Gooskens S, et al
    Somatic thrombopoietin (THPO) gene mutations in childhood myeloid leukemias.
    Int J Hematol. 2015;102:140-3.
    PubMed     Text format     Abstract available


    June 2015
  105. LI Y, Durig J, Gobel M, Hanoun M, et al
    Functional abnormalities and changes in gene expression in fibroblasts and macrophages from the bone marrow of patients with acute myeloid leukemia.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


  106. WEN L, Xia J, Wang Q, Yao H, et al
    Prognostic impact of residual normal metaphases in acute myeloid leukemia with t(8;21)(q22;q22).
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


  107. SREEDHARANUNNI S, Varma N, Sachdeva MU, Gupta K, et al
    CD103+ gammadelta T cell large granular lymphocytosis in a patient with refractory celiac disease: a diagnostic enigma.
    Int J Hematol. 2015;101:603-7.
    PubMed     Text format     Abstract available


    May 2015
  108. BEKTAS O, Uner A, Aydin SM, Eliacik E, et al
    High frequency of autonomous T-cell proliferation compatible with T-cell large granular lymphocytic leukemia in patients with cytopenia of unknown etiology.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


    April 2015
  109. FRIEDMAN AD
    C/EBPalpha in normal and malignant myelopoiesis.
    Int J Hematol. 2015;101:330-41.
    PubMed     Text format     Abstract available


  110. IMPERATO MR, Cauchy P, Obier N, Bonifer C, et al
    The RUNX1-PU.1 axis in the control of hematopoiesis.
    Int J Hematol. 2015;101:319-29.
    PubMed     Text format     Abstract available


  111. TAMURA T, Kurotaki D, Koizumi S
    Regulation of myelopoiesis by the transcription factor IRF8.
    Int J Hematol. 2015;101:342-51.
    PubMed     Text format     Abstract available


  112. KAWASHIMA-GOTO S, Imamura T, Seki M, Kato M, et al
    Identification of a homozygous JAK3 V674A mutation caused by acquired uniparental disomy in a relapsed early T-cell precursor ALL patient.
    Int J Hematol. 2015;101:411-6.
    PubMed     Text format     Abstract available


    March 2015
  113. RODRIGUEZ D, Bretones G, Arango JR, Valdespino V, et al
    Molecular pathogenesis of CLL and its evolution.
    Int J Hematol. 2015;101:219-28.
    PubMed     Text format     Abstract available


  114. ZOI K, Cross NC
    Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable.
    Int J Hematol. 2015;101:229-42.
    PubMed     Text format     Abstract available


    February 2015
  115. PECHEY V, Parratt J, Vo L, Stevenson W, et al
    Successful treatment of meningeal graft-versus-host disease in a haematopoietic stem cell transplant recipient.
    Int J Hematol. 2015;101:203-6.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: